Advertisement
Advertisement

ETNB

ETNB logo

89bio, Inc. Common Stock

10.40
USD
+0.78
+8.10%
Jun 13, 15:59 UTC -4
Closed
exchange

After-Market

9.85

-0.55
-5.32%

89bio, Inc. Common Stock Profile

About

89bio Inc. is clinical-stage biopharmaceutical company. It is focused on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. The company's lead product candidate, BIO89-100, is being developed for the treatment of nonalcoholic steatohepatitis. 89bio Inc. is headquartered in San Francisco.

Info & Links

CEO

Rohan Palekar

Headquarters

655 MONTGOMERY STREET, SUITE 1500
SAN FRANCISCO, CA 94111, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.89bio.com

Auditor

KPMG LLP

Share holders

5

Employees

93

89bio, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

1.44B

Enterprise Value

1.16B

Enterprise Value/EBITDA(ttm)

-2.81

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

2.85

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-59.58%

Return on Invested Capital(ttm)

-83.23%

Return on Assets(ttm)

-52.21%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-412.10M

Net Income Available to Common(ttm)

-386.67M

Diluted EPS(ttm)

-2.91

Share Statistics

Beta (5Y Monthly)

1.17

52-Week Change

18.57%

S&P 500 52-Week Change

9.20%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

145.98M

Dividend Yield

0.00%

Float4

103.15M

% Held by Insiders

2.80%

% Held by Institutions

--

Balance Sheet

Total Cash(mrq)

638.78M

Total Cash Per Share(mrq)

4.38

Total Debt(mrq)

35.94M

Total Debt/Equity(mrq)

5.94%

Current Ratio(mrq)

18.03%

Quick Ratio(mrq)

11.66%

Book Value Per Share(mrq)

4.15

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.49

Free Cash Flow(ytd)

-71.81M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement